Lassa Fever Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies -Arisan Therapeutics, Kineta Inc

(Las Vegas, Nevada, United States) DelveInsight's "Lassa Fever Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Lassa Fever, historical and forecasted epidemiology as well as the Lassa Fever market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Download Sample Report to know more
@https://www.delveinsight.com/sample-request/lassa-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Lassa Fever Overview
Lassa fever, also known as Lassa hemorrhagic fever, is a type of viral hemorrhagic fever caused by the Lassa virus. Many of those infected by the virus do not develop symptoms. When symptoms occur they typically include fever, weakness, headaches, vomiting, and muscle pains. Less commonly there may be bleeding from the mouth or gastrointestinal tract. The risk of death once infected is about one percent and frequently occurs within two weeks of the onset of symptoms. Of those who survive, about a quarter have hearing loss, which improves within three months in about half of these cases.
The disease is usually initially spread to people via contact with the urine or feces of an infected multimammate mouse. Spread can then occur via direct contact between people. Diagnosis based on symptoms is difficult. Confirmation is by laboratory testing to detect the virus's RNA, antibodies for the virus, or the virus itself in cell culture. Other conditions that may present similarly include Ebola, malaria, typhoid fever, and yellow fever. The Lassa virus is a member of the Arenaviridae family of viruses.

Click here to learn more about the Lassa Fever Market Landscape @https://www.delveinsight.com/report-store/lassa-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Key Highlights from Lassa Fever Market Report
There are about 300,000 to 500,000 cases which result in 5,000 deaths a year.One estimate places the number as high as 3 million cases per year.
Estimates of Lassa fever are complicated by the lack of easy-available diagnosis, limited public health surveillance infrastructure, and high clustering of incidence near high-intensity sampling.
The infection affects females 1.2 times more than males. The age group predominantly infected is 21-30 years.

Lassa Fever Treatment Market
Ribavirin, an antiviral drug, has been used with success in Lassa fever patients. It is most effective when given early in the course of the illness. Patients also receive supportive care consisting of maintenance of appropriate fluid and electrolyte balance, oxygenation, and blood pressure, as well as treatment of any other complicating infections. Primary transmission of the Lassa virus from its host to humans can be prevented by avoiding contact with Mastomys rodents, especially in the geographic regions where outbreaks occur.

Learn more about the treatment market for Lassa Fever @ https://www.delveinsight.com/report-store/lassa-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

The Report Covers the Lassa Fever Epidemiology Segmented by:
Lassa Fever prevalent cases
Lassa Fever Incident Cases
Lassa Fever treatment cases
Lassa Fever diagnosed cases
Lassa Fever Dug Profile and Companies Covered
Arisan Therapeutics
Kineta Inc
And many others.

Learn more about the Key Companies and Emerging Therapies in the Lassa Fever Market @https://www.delveinsight.com/report-store/lassa-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Table of Contents
Key Insights
Lassa Fever Introduction
Executive Summary of Lassa Fever
Disease Background and Overview
Lassa Fever Epidemiology and patient population
Lassa Fever Emerging Therapies
Lassa Fever Market Outlook
Lassa Fever Market Access and Reimbursement of Therapies
Lassa Fever Market Drivers
Lassa Fever Market Barriers
Appendix
Lassa Fever Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Lassa Fever Market Outlook report @ https://www.delveinsight.com/report-store/lassa-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Related Reports
Lassa Fever Epidemiology Forecast
https://www.delveinsight.com/report-store/lassa-fever-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Lassa Fever Pipeline Forecast
https://www.delveinsight.com/report-store/lassa-fever-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.